Billions Are Still Needed To Distribute A COVID Vaccine, With No Relief In Sight

WASHINGTON, DC - SEPTEMBER 30: Senate Majority Leader Mitch McConnell (R-KY) participates in a news conference following the weekly Senate Republican policy luncheon in the Hart Senate Office Building on Capitol Hill... WASHINGTON, DC - SEPTEMBER 30: Senate Majority Leader Mitch McConnell (R-KY) participates in a news conference following the weekly Senate Republican policy luncheon in the Hart Senate Office Building on Capitol Hill on September 30, 2020 in Washington, DC. Despite talks between Treasury Secretary Steven Mnuchin and Speaker of the House Nancy Pelosi (D-CA), McConnell said that Senate Republicans and House Democrats are still far apart on coronavirus relief legislation. (Photo by Chip Somodevilla/Getty Images) MORE LESS
|
October 20, 2020 10:22 a.m.
EDITORS' NOTE: TPM is making our COVID-19 coverage free to all readers during this national health crisis. If you’d like to support TPM's reporters, editors and staff, the best way to do so is to become a member.

North Dakota got $400,000, at around 50 cents a resident. California got $28 million — 70 cents a resident.

That’s the amount that those states have received from the Centers for Disease Control to help distribute a COVID-19 vaccine. Nothing more.

The rest of the money was supposed to come in a second stimulus package. But it hasn’t, amid opposition from Senate Republicans to further spending and ongoing negotiations between House Democrats, Treasury Secretary Steve Mnuchin, and the White House.

The lack of funding threatens to choke off the country’s vaccine response, depriving the states — and the CDC — of everything from the ability to hire vaccinators to the ultra-cold freezers needed to store doses.

“I just don’t want to know what would happen,” Claire Hannan, head of the association of immunization managers, told TPM, when asked about the consequences of the lack of funding in the coming months.

Filling the gap will require $8.4 billion in new funding, the Association of Immunization Managers and the Association of State and Territorial Health Officials said in an Oct. 15 letter demanding that congressional leaders find the money.

The lack of aid comes as the country grapples with a new bout of skyrocketing COVID-19 cases, with hospitals in areas around the country brimming to capacity.

“The next 6 to 12 weeks are going to be the darkest of the entire pandemic,” said Dr. Michael Osterholm, director of the center for infectious disease research at the University of Minnesota. “Vaccines will not become available in any meaningful way until early to third quarter of next year.”

President Trump has bluffed that a vaccine will be available before the Nov. 3 election, and has separately claimed that it will be possible for the general public to get one within months.

Though regulators and scientists appear to have mostly fought off President Trump’s bid to have a COVID-19 vaccine approved before the data showed that it works safely, the lack of funding means that state and local health departments are already behind where they need to be to prepare to distribute doses to the public.

“That funding should have been provided already, and it’s frustrating that it hasn’t been,” Hannan said.

Paul Mango, a senior official with Operation Warp Speed, the Trump administration’s effort to speed up COVID-19 vaccine development, told reporters last week that a vaccine would be “in people’s arms within 24–48 hours” of receiving emergency approval from the FDA.

At the same time, the CDC’s Advisory Committee on Immunization Practices will analyze data from the vaccine trials to determine how it should be distributed, and in what groups of people it is the most effective and safest.

All 50 states faced an Oct. 16 deadline to provide plans to the CDC detailing how they intend to distribute a COVID-19 vaccine, and describing who state health authorities will prioritize in receiving the vaccine.

Hannan noted that that was difficult to accomplish given the lack of data from the ongoing clinical trials. The exercise in developing a plan without knowing how the eventual COVID-19 vaccine will work — and how efficient it will be once approved — sparked questions among state governors as well.

The National Governor’s Association released a list of questions for the Trump administration over how a vaccine will be distributed.

First on the list was “will there be funding allocated to states to assist with distribution of the vaccine and other vaccine efforts? ”

The money would go to a range of services needed to build infrastructure to distribute the doses. Health departments need money for ultra-cold freezers that can store the Pfizer vaccine candidate, which requires sub-zero temperatures to remain viable.

Others need money to train staff to vaccinate people, and need even more to hire staff to train the vaccinators themselves. Hannan added that the lack of funding could force local health departments to cut further costs amid an already-existing budget.

“They can move some funding around, but for them to staff up, they’ll need more,” Hannan said.

Key Coronavirus Crisis Links

TPM’s COVID-19 hub.
Josh Marshall’s Twitter List of Trusted Experts (Epidemiologists, Researchers, Clinicians, Journalists, Government Agencies) providing reliable real-time information on the COVID-19 Crisis.
COVID-19 Tracking Project (updated data on testing and infections in the U.S.).
Johns Hopkins Global COVID-19 Survey (most up to date numbers globally and for countries around the world).
Worldometers.info (extensive source of information and data visualizations on COVID-19 Crisis — discussion of data here).
Latest News
Comments
Masthead Masthead
Founder & Editor-in-Chief:
Executive Editor:
Managing Editor:
Senior Editor:
Special Projects Editor:
Editor at Large:
General Counsel:
Publisher:
Head of Product:
Director of Technology:
Associate Publisher:
Front-End Developer:
Senior Designer:
SPECIAL DEAL FOR PAST TPM MEMBERS
40% OFF AN ANNUAL PRIME MEMBERSHIP
REJOIN FOR JUST $30